6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
ID: 36C77025Q0038Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    (913) 684-0140
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    The document pertains to a federal Request for Proposal (RFP) issued by the Department of Veterans Affairs for the procurement of Sevelamer Carbonate 800MG Tablets for multiple CMOP (Consolidated Mail Outpatient Pharmacy) locations. The procurement is open to various eligible business categories, including small and veteran-owned enterprises. It outlines key contractual and delivery guidelines, including shipping requirements via USPS, invoicing procedures, and quality assurance measures. The solicitation specifies that offers must include detailed information about pharmaceutical products, including National Drug Codes (NDCs), bar code labeling requirements, product availability commitments, and compliance with the Drug Supply Chain Security Act. The document also establishes a framework for contract administration, including invoicing and tracking deliveries to ensure proper compliance and fulfillment of standards. In summary, the RFP aims to ensure efficient procurement and delivery of pharmaceuticals critical to veterans’ healthcare while maintaining compliance with federal regulations and encouraging participation from diverse businesses.
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The solicitation number is 36C77025Q0038, with a response deadline set for October 31, 2024. The contract is categorized under full and open competition for drugs and biologicals classified with Product Service Code 6505 and NAICS Code 325412. The required quantities span across various CMOP locations, including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston, with a total of 8,480 tablets to be supplied. Offerors must comply with the Drug Supply Chain Security Act and submit relevant documentation with their quotations. This includes their state wholesale distributor license, a signed solicitation cover page, and a Trade Agreements Act certificate. All proposals must be submitted via email to the designated contracting specialist, Kelley Cunningham. This presolicitation reflects the VA's commitment to ensuring an adequate supply of pharmaceuticals for the veteran population while adhering to regulatory and procedural guidelines.
    The document outlines a Request for Quote (RFQ) from the VA for the procurement of pharmaceuticals, specifically SEVELAMER CARBONATE 800MG TAB. The solicitation, referenced by RFQ number 36C77025Q0038, has a posted date of October 25, 2024, with a closing date set for October 31, 2024, at 3:00 PM Central Time. Vendors are required to submit a signed SF1449 cover page, a completed quote spreadsheet, and relevant licenses including a State Wholesale Distributor License and a Trade Agreement Act (TAA) Certificate. The document emphasizes that only TAA compliant quotes will be considered, and specifies that all pharmaceutical products must have a minimum expiration of one year from the delivery date. It provides a line-item listing of quantities, pricing, and vendor comments related to orders being placed at various VA Centralized Medical Operations (CMOP) facilities. This RFQ serves as a critical mechanism for ensuring the procurement of medically necessary supplies for veteran care, underscoring the importance of compliance with government contracting standards and regulations.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0108 770-25-1-801-0136 -National CMOP FENOFIBRATE 48mg
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate 48mg tablets for the National CMOP (Consolidated Mail Outpatient Pharmacy) facility. The solicitation, numbered 36C77025Q0108, requires vendors to provide specific quantities of the medication, with strict adherence to the Drug Supply Chain Security Act and the Buy American statute. This procurement is critical for ensuring the timely delivery of essential pharmaceuticals to veterans, with a closing date for submissions set for January 8, 2025, at 9:00 AM CST, and an estimated award date of January 13, 2025. Interested parties should submit their quotes and required documentation, including a signed SF1449 form and state wholesale distributor license, to Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    6505--Nadolol Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0014 concerning the procurement of Nadolol Tablets. This procurement aims to secure an uninterrupted supply of Nadolol Tablets for various federal health entities, including the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 7,753 bottles of 20MG, 6,085 bottles of 40MG, and 1,566 bottles of 80MG tablets, all of which must feature unique labeling (NDC number) as specified. The solicitation is expected to be released electronically on or around January 10, 2025, with responses due by January 27, 2025. Interested suppliers can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov.
    Q517--Staffing Service for Murfreesboro CMOP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services at the Murfreesboro Consolidated Mail Outpatient Pharmacy (CMOP) in Tennessee, specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contract requires the provision of pharmacists, pharmacy technicians, and shipper/packer personnel to support operations that process over 15 million prescriptions annually, ensuring compliance with VA guidelines and operational standards. This initiative is crucial for maintaining efficient pharmaceutical services for veterans, reflecting the government's commitment to quality healthcare delivery. Interested contractors must submit their proposals by the revised deadline of July 30, 2024, with a minimum guaranteed contract value of $5 million and a maximum of $300 million over the contract's duration, which spans from April 1, 2023, to March 31, 2028. For further inquiries, potential bidders can contact Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.